(Q46374395)

21 December 2017

title

Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention (English)

1 reference

21 December 2017

1 reference

4

1 reference

21 December 2017

author name string

Simon M G Smith

series ordinal

1

1 reference

21 December 2017

Heather M Judge

series ordinal

2

1 reference

21 December 2017

Gary Peters

series ordinal

3

1 reference

21 December 2017

publication date

1 December 2004

1 reference

21 December 2017

published in

Platelets

1 reference

21 December 2017

volume

15

1 reference

21 December 2017

issue

8

1 reference

21 December 2017

page(s)

465-474

1 reference

21 December 2017

Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease

cites work

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function — a flow cytometry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Statins do not affect platelet inhibition with clopidogrel during coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Effects of Statins on Platelet Inhibition by a High Loading Dose of Clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Effect of loading with clopidogrel at the time of coronary stenting on platelet aggregation and glycoprotein IIb/IIIa expression and platelet-leukocyte aggregate formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0953710412331272532

10.1080/0953710412331272532

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017